Literature DB >> 2144014

Constitutive expression of interleukin-7 mRNA and production of IL-7 by a cloned murine thymic stromal cell line.

T Sakata1, S Iwagami, Y Tsuruta, H Teraoka, Y Tatsumi, Y Kita, S Nishikawa, Y Takai, H Fujiwara.   

Abstract

Mouse interleukin-7 (IL-7) cDNA was cloned from mouse thymic stromal cell clone MRL 104.8a using a polymerase chain reaction (PCR) technique and expressed in COS-7 cells. The resulting recombinant interleukin-7 (rIL-7) supported the proliferation of mouse antigen-specific helper T cell (Th) clone 9-16 in the absence of IL-2 and antigen as well as mouse pre-B cell line DW34. It was also found that high levels of the mRNA for IL-7 were constitutively expressed in the MRL104.8a cells, and a potent amount of IL-7 was produced in its culture supernatant. These results provide the evidence for constitutive expression of IL-7 mRNA and for production of IL-7 by thymic stromal cells that have a critical role in intrathymic T cell development. The results are discussed in the context of the functional and molecular relationship between IL-7 and the previously described cytokines produced by thymic stromal cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144014     DOI: 10.1002/jlb.48.3.205

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  17 in total

1.  Homeostatic expansion and phenotypic conversion of human T cells depend on peripheral interactions with APCs.

Authors:  Takashi Onoe; Hannes Kalscheuer; Meredith Chittenden; Guiling Zhao; Yong-Guang Yang; Megan Sykes
Journal:  J Immunol       Date:  2010-05-10       Impact factor: 5.422

Review 2.  Clinical strategies to enhance T cell reconstitution.

Authors:  Gabrielle L Goldberg; Johannes L Zakrzewski; Miguel A Perales; Marcel R M van den Brink
Journal:  Semin Immunol       Date:  2007-10-26       Impact factor: 11.130

3.  Functional deficiency in IL-7 caused by an N-ethyl-N-nitrosourea-induced point mutation.

Authors:  Jianxun Feng; Hongsheng Wang; Herbert C Morse
Journal:  Genetics       Date:  2006-12-18       Impact factor: 4.562

4.  Autocrine expression of interleukin-7 rescues lymphoid expansion in interleukin-7-deficient mice.

Authors:  B E Rich
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

5.  Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.

Authors:  Miguel-Angel Perales; Jenna D Goldberg; Jianda Yuan; Guenther Koehne; Lauren Lechner; Esperanza B Papadopoulos; James W Young; Ann A Jakubowski; Bushra Zaidi; Humilidad Gallardo; Cailian Liu; Teresa Rasalan; Jedd D Wolchok; Therese Croughs; Michel Morre; Sean M Devlin; Marcel R M van den Brink
Journal:  Blood       Date:  2012-09-25       Impact factor: 22.113

Review 6.  Rejuvenation of the aging T cell compartment.

Authors:  Amanda M Holland; Marcel R M van den Brink
Journal:  Curr Opin Immunol       Date:  2009-07-14       Impact factor: 7.486

7.  High-level replication of human immunodeficiency virus in thymocytes requires NF-kappaB activation through interaction with thymic epithelial cells.

Authors:  L Chêne; M T Nugeyre; F Barré-Sinoussi; N Israël
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Adhesion of immature thymocytes to thymic stromal cells through fibronectin molecules and its significance for the induction of thymocyte differentiation.

Authors:  K Utsumi; M Sawada; S Narumiya; J Nagamine; T Sakata; S Iwagami; Y Kita; H Teraoka; H Hirano; M Ogata
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

Review 9.  Thymic involution and immune reconstitution.

Authors:  Heather E Lynch; Gabrielle L Goldberg; Ann Chidgey; Marcel R M Van den Brink; Richard Boyd; Gregory D Sempowski
Journal:  Trends Immunol       Date:  2009-06-18       Impact factor: 16.687

10.  Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules.

Authors:  R Costello; H Brailly; F Mallet; C Mawas; D Olive
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.